BGB-10188

BGB-10188 · BeiGene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGB-10188, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab [Phase 1, Phase 2]